Outlook for once-trouble Karmanos Institute brightens
After coming close to losing its federal backing, Detroit 's Barbara Ann Karmanos Cancer Institute is working its way toward becoming a top national cancer center. Karmanos President and CEO John Ruckdeschel said the main reason the institute received borderline rankings and anemic funding after a 2001 review from the National Cancer Institute was a campaign by his predecessor for a controversial breast cancer treatment that diverted attention from other areas of research. Gloria Heppner, who was deputy director of the institute under William Peters and associate vice president for research at the WSU School of Medicine, said Peters was an innovator who put Karmanos on the map, but his enthusiasm had a price. She said Peters' tumultuous relationship with the NCI "didn't help us, but he brought a lot to the institute."